← 產業報告目錄
RNA Analysis Transcriptomics Market Size, Share & Trends Analysis Report By Type (Consumables, Instruments, Software, Services), By Application, By Technology (Microarrays, qPCR, Sequencing Technology), By Region, And By Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-01-23頁數 175報告編號 INSIGHTACE-8ee7f963df
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The RNA Analysis Transcriptomics Market on a global scale was estimated at USD 13.0 Bn in 2024 and is projected to attain USD 67.8 Bn by 2034, with a projected CAGR of 18.2% between 2025 and 2034.
RNA Analysis Transcriptomics encompasses key industry insights & findings from the report:
Expanding awareness of infectious diseases, decreasing sequencing costs, and growth in genomics in rna transcripts are driving forces behind the mark. The sector has gained traction as organizations seek innovative approaches to address evolving healthcare challenges.
The market's upward path is propelled by rising healthcare spending, technological evolution, and the rising focus on personalized and precision-based approaches in healthcare.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region projected to deliver the strongest growth trajectory through the forecast period, propelled by demographic shifts and policy support.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global RNA Analysis Transcriptomics Market Snapshot
Chapter 4. Global RNA Analysis Transcriptomics Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Product Type Estimates & Trend Analysis
5.1. by Product Type & Market Share, 2024 & 2034
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Product Type:
5.2.1. Consumables
5.2.2. Instruments
5.2.3. Software
5.2.4. Services
Chapter 6. Market Segmentation 2: by Technology Estimates & Trend Analysis
6.1. by Technology & Market Share, 2024 & 2034
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Technology:
6.2.1. Microarrays
6.2.2. qPCR
6.2.3. Sequencing Technology
Chapter 7. Market Segmentation 3: by Application Estimates & Trend Analysis
7.1. by Application & Market Share, 2024 & 2034
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Application:
7.2.1. Drug Discovery
7.2.2. Diagnostics and Disease Profiling
7.2.3. Others
Chapter 8. RNA Analysis Transcriptomics Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America RNA Analysis Transcriptomics Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034
8.1.2. North America RNA Analysis Transcriptomics Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
8.1.3. North America RNA Analysis Transcriptomics Market revenue (US$ Million) by Application, 2021-2034
8.1.4. North America RNA Analysis Transcriptomics Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
8.2. Europe
8.2.1. Europe RNA Analysis Transcriptomics Market revenue (US$ Million) by Product Type, 2021-2034
8.2.2. Europe RNA Analysis Transcriptomics Market revenue (US$ Million) by Technology, 2021-2034
8.2.3. Europe RNA Analysis Transcriptomics Market revenue (US$ Million) by Application, 2021-2034
8.2.4. Europe RNA Analysis Transcriptomics Market revenue (US$ Million) by country, 2021-2034
8.3. Asia Pacific
8.3.1. Asia Pacific RNA Analysis Transcriptomics Market revenue (US$ Million) by Product Type, 2021-2034
8.3.2. Asia Pacific RNA Analysis Transcriptomics Market revenue (US$ Million) by Technology, 2021-2034
8.3.3. Asia-Pacific RNA Analysis Transcriptomics Market revenue (US$ Million) by Application, 2021-2034
8.3.4. Asia Pacific RNA Analysis Transcriptomics Market revenue (US$ Million) by country, 2021-2034
8.4. Latin America
8.4.1. Latin America RNA Analysis Transcriptomics Market revenue (US$ Million) by Product Type, 2021-2034
8.4.2. Latin America RNA Analysis Transcriptomics Market revenue (US$ Million) by Technology, 2021-2034
8.4.3. Latin America RNA Analysis Transcriptomics Market revenue (US$ Million) by Application, 2021-2034
8.4.4. Latin America RNA Analysis Transcriptomics Market revenue (US$ Million) by country, 2021-2034
8.5. Middle East & Africa
8.5.1. Middle East & Africa RNA Analysis Transcriptomics Market revenue (US$ Million) by Product Type, 2021-2034
8.5.2. Middle East & Africa RNA Analysis Transcriptomics Market revenue (US$ Million) by Technology, 2021-2034
8.5.3. Middle East & Africa RNA Analysis Transcriptomics Market revenue (US$ Million) by Application, 2021-2034
8.5.4. Middle East & Africa RNA Analysis Transcriptomics Market revenue (US$ Million) by country, 2021-2034
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Agilent Technologies Inc.
9.2.2. Bio-Rad Laboratories
9.2.3. F-Hoffmann La-Roche
9.2.4. Fluidigm Corporation
9.2.5. General Electric Company
9.2.6. Illuminia Inc.
9.2.7. Merck & Co. Inc
9.2.8. Promega Corporation
9.2.9. Qiagen, Inc.
9.2.10. Thermofisher Scientific
9.2.11. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們